Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor XIII supplementation after craniotomy to prevent postoperative intracranial hemorrhage
jRCTs051250079Recruiting
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Factor XIII (human) in intracerebral hemorrhage (ICH). Primary endpoint: Incidence of postoperative intracranial hemorrhage requiring reoperation. Started Sep 2025; status: recruiting.
02
Drugs
Factor XIII (human)
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on jRCTs051250079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250079.